title: AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma.
abstract: AHNAK/Desmoyokin is a giant protein which has been recently linked to reorganization of the actin cytoskeleton, cellular migration and invasion. Here, we investigated the role of AHNAK in the pathophysiology of larynx carcinoma-one of the major subtypes of head and neck cancer. To this end, we analysed AHNAK expression in tumor tissues from 83 larynx carcinoma patients in relation to overall survival. We found that tumoral AHNAK overexpression significantly associated with poor survival of these patients both in univariate and multivariate analysis. In further studies, we combined the prognostic value of AHNAK with selected markers of inflammation, such as macrophage migration inhibitory factor (MIF) and tumor-infiltrating neutrophils (CD66b-positive cells). Both MIF and neutrophils have been linked to enhanced tumoral migration and poor clinical outcome in patients with orohypopharynx carcinoma-another major subtype of head and neck cancer. Interestingly, we found that synchronous high levels of AHNAK and MIF or AHNAK and neutrophils, respectively, were stronger predictors of poor survival than AHNAK alone. Synchronous high levels of all three markers were the strongest predictors of poor survival in our patient cohort. Taken together, our findings propose novel strategies for an accurate prognosis in larynx carcinoma and suggest potential mechanisms of inflammation-mediated tumor progression.
authors: Department of Otorhinolaryngology, University of Duisburg-Essen, Essen, Germany. claudia.dumitru@uni-due.de
authors: Claudia A
authors: CA
authors: Dumitru
authors: Agnes
authors: A
authors: Bankfalvi
authors: Xiang
authors: X
authors: Gu
authors: Reinhard
authors: R
authors: Zeidler
authors: Sven
authors: S
authors: Brandau
authors: Stephan
authors: S
authors: Lang
mesh_terms: D015703:Antigens, CD / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000378:metabolism*; D015815:Cell Adhesion Molecules / Q000378:metabolism; D018450:Disease Progression; D005260:Female; D058851:GPI-Linked Proteins / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D007822:Laryngeal Neoplasms / Q000175:diagnosis* / Q000378:metabolism*; D008263:Macrophage Migration-Inhibitory Factors / Q000378:metabolism; D008297:Male; D008565:Membrane Proteins / Q000378:metabolism*; D015999:Multivariate Analysis; D009363:Neoplasm Proteins / Q000378:metabolism*; D011379:Prognosis; D016019:Survival Analysis
chemical_list: C075176:AHNAK protein, human; D015703:Antigens, CD; D014408:Biomarkers, Tumor; C504120:CEACAM8 protein, human; D015815:Cell Adhesion Molecules; D058851:GPI-Linked Proteins; D008263:Macrophage Migration-Inhibitory Factors; D008565:Membrane Proteins; D009363:Neoplasm Proteins